You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hh pathway inhibitor,

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumors, Adult, Solid Tumor, Mesothelioma (MPM) Trial in United States (IK-930)

Recruiting
  • Solid Tumors, Adult
  • +7 more
  • Boston, Massachusetts
  • +6 more
Jan 24, 2023

Basal Cell Carcinoma, Basal Cell Nevus Syndrome Trial in Australia (ASN-002)

Recruiting
  • Basal Cell Carcinoma
  • Basal Cell Nevus Syndrome
  • ASN-002
  • Brisbane, Queensland, Australia
  • +5 more
Feb 10, 2022

Advanced Solid Tumors Harboring MAPK Pathway Alterations Trial in Shandong (QLH11906)

Recruiting
  • Advanced Solid Tumors Harboring MAPK Pathway Alterations
  • Shandong, China
    Shandong Cancer Hospital
Aug 3, 2022

Menstrual Bleeding, Heavy Trial in Portland (Sample Collection and Endometrial Biopsy)

Not yet recruiting
  • Menstrual Bleeding, Heavy
  • Sample Collection and Endometrial Biopsy
  • Portland, Oregon
    OHSU
May 8, 2023

Solid Tumor, Advanced Solid Tumor, Non Small Cell Lung Cancer Trial in Denver, Nashville, Fairfax (MRTX0902, MRTX849)

Recruiting
  • Solid Tumor
  • +3 more
  • Denver, Colorado
  • +2 more
Dec 19, 2022

Mesothelioma, Uveal Melanoma, Renal Cell Carcinoma Trial in Gainesville, Miami, Orlando (Niraparib)

Completed
  • Mesothelioma
  • +3 more
  • Gainesville, Florida
  • +2 more
Jan 4, 2023

Recurrent Endometrial Carcinoma, Recurrent Ovarian Carcinoma Trial (Biopsy, Biospecimen Collection, Bone Marrow Aspiration and

Not yet recruiting
  • Recurrent Endometrial Carcinoma
  • Recurrent Ovarian Carcinoma
  • Biopsy
  • +5 more
  • (no location specified)
Sep 29, 2022

Myocardial Infarction, Myocardial Fibrosis, Myocardial Remodeling, Ventricular Trial in Messina (P2Y12 Potent Inhibitor +

Recruiting
  • Myocardial Infarction
  • +2 more
  • P2Y12 Potent Inhibitor + Aspirin for STEMI patients
  • Clopidogrel + Aspirin for CCS patients
  • Messina, Italy
    AOU Policlinico G. Martino
Jan 21, 2023

In Vitro Correction of Thrombin Generation by Concizumab for

Recruiting
  • Hemophilia
  • thrombin generation measurement
  • Saint-Etienne, France
    CHU Saint-Etienne
Dec 13, 2022

Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma Trial in France, United Kingdom, United States (NUC-3373 +

Recruiting
  • Colorectal Cancer
  • +4 more
  • NUC-3373 + leucovorin
  • +8 more
  • Boston, Massachusetts
  • +9 more
Jan 23, 2023

Prostate Cancer Trial in Boston, Brooklyn, New York (225Ac-J591, Pembrolizumab, Androgen receptor pathway inhibitor)

Recruiting
  • Prostate Cancer
  • Boston, Massachusetts
  • +3 more
Sep 20, 2021

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial (Pharmacotherapy

Not yet recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +4 more
  • Pharmacotherapy Discontinuation
  • +3 more
  • (no location specified)
Feb 11, 2022

NSCLC, Progression of NSCLC, NSCLC Recurrent Trial in Saint Louis, Cincinnati (Docetaxel, Tergenpumatucel-L, Indoximod)

Terminated
  • Non-small Cell Lung Cancer
  • +2 more
  • Saint Louis, Missouri
  • +1 more
Apr 4, 2022

Breast Cancer Trial (Ribociclib)

No longer available
  • Breast Cancer
  • (no location specified)
Feb 15, 2022

Carcinoma, Basal Cell Trial in Worldwide (cemiplimab)

Active, not recruiting
Has Results
  • Carcinoma, Basal Cell
  • Phoenix, Arizona
  • +70 more
Jun 30, 2022

Neurofibromatosis Type 1, Plexiform Neurofibroma, Optic Nerve Glioma Trial in London (Selumetinib)

Recruiting
  • Neurofibromatosis Type 1
  • +2 more
  • London, United Kingdom
  • +1 more
Nov 11, 2021

Cabozantinib Post First-line Immuno-oncology Checkpoint

Completed
  • Advanced Renal Cell Carcinoma (aRCC)
    • Glasgow, United Kingdom
    • +8 more
    Jun 30, 2022

    Rare Tumor, Refractory Tumor Trial in Shanghai (Gefitinib, Erlotinib, Afatinib)

    Recruiting
    • Rare Tumor
    • Refractory Tumor
    • Shanghai, Shanghai, China
      Shanghai Changzheng Hospital
    Feb 16, 2022

    Chronic Lymphocytic Leukemia Trial in United States (ABT-199)

    Completed
    • Chronic Lymphocytic Leukemia
    • La Jolla, California
    • +14 more
    Dec 29, 2021

    Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)

    Active, not recruiting
    • Advanced Breast Cancer
    • +2 more
    • Talazoparib Tosylate
    • Stanford, California
      Stanford University Hospitals and Clinics
    Nov 16, 2022

    Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in Boston, Galveston,

    Suspended
    • Advanced Malignant Solid Neoplasm
    • +4 more
    • Boston, Massachusetts
    • +2 more
    Oct 5, 2022

    Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal

    Recruiting
    • Borderline Resectable Pancreatic Adenocarcinoma
    • +11 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Mar 22, 2022

    Neurofibromatosis Type 1-Associated Plexiform Neurofibromas, Histiocytic Tumor, Other MAP-K Pathway Driven Diseases Trial

    Available
    • Neurofibromatosis Type 1-Associated Plexiform Neurofibromas
    • +2 more
    • Mirdametinib (MEK Inhibitor)
    • (no location specified)
    Aug 24, 2021

    Adult Acute Myeloid Leukemia in Remission, Recurrent Adult Acute Myeloid Leukemia Trial in Aurora, Columbus (PF-04449913)

    Completed
    Has Results
    • Adult Acute Myeloid Leukemia in Remission
    • Recurrent Adult Acute Myeloid Leukemia
    • Aurora, Colorado
    • +1 more
    Dec 30, 2021

    Metastatic Basal Cell Carcinoma, Locally Advanced Basal Cell Carcinoma Trial in Bordeaux (Treatment with vismodegib)

    Completed
    • Metastatic Basal Cell Carcinoma
    • Locally Advanced Basal Cell Carcinoma
    • Treatment with vismodegib
    • Bordeaux, France
      Chu de Bordeaux
    Aug 17, 2022